National Health Investors (NYSE:NHI) Issues FY24 Earnings Guidance

National Health Investors (NYSE:NHI) updated its FY24 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $4.43-$4.44 for the period, compared to the consensus estimate of $4.52. National Health Investors also updated its FY 2024 guidance to 4.430-4.440 EPS.

National Health Investors Trading Up 1.1 %

Shares of National Health Investors stock traded up $0.81 during mid-day trading on Tuesday, hitting $76.73. 340,585 shares of the stock were exchanged, compared to its average volume of 190,436. The stock has a market capitalization of $3.33 billion, a price-to-earnings ratio of 26.00, a price-to-earnings-growth ratio of 5.09 and a beta of 1.05. National Health Investors has a twelve month low of $49.25 and a twelve month high of $86.13. The company has a current ratio of 10.27, a quick ratio of 10.27 and a debt-to-equity ratio of 0.91. The company has a 50-day simple moving average of $80.53 and a 200 day simple moving average of $73.03.

National Health Investors (NYSE:NHI) last released its earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 EPS for the quarter, missing the consensus estimate of $1.10 by ($0.29). National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The firm had revenue of $84.97 million during the quarter, compared to analysts’ expectations of $64.95 million. During the same period in the previous year, the firm posted $1.06 earnings per share. The firm’s revenue was up 9.1% on a year-over-year basis. Research analysts forecast that National Health Investors will post 4.48 EPS for the current year.

Analysts Set New Price Targets

NHI has been the topic of several research analyst reports. StockNews.com cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Truist Financial boosted their price objective on shares of National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a research note on Friday, August 30th. Bank of America started coverage on National Health Investors in a report on Tuesday, September 24th. They issued a “buy” rating and a $92.00 target price on the stock. Finally, Wells Fargo & Company lowered shares of National Health Investors from an “overweight” rating to an “equal weight” rating and increased their price objective for the stock from $81.00 to $86.00 in a research report on Tuesday, October 1st. Four research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, National Health Investors currently has an average rating of “Moderate Buy” and a consensus price target of $73.29.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.